Home » Topics » Regulatory

Regulatory
RSS

Japanese authorities extend indication of Venogloblulin

Sep. 27, 2011

Asahi Kasei Pharma clear to market osteoporosis therapy in Japan

Sep. 27, 2011

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

European approval of Removab broadened

Sep. 21, 2011

FDA approves Prolia for new indications

Sep. 20, 2011

Ono Pharmaceutical secures new Japanese approval for Glactiv

Sep. 19, 2011

Vibativ approved in Europe

Sep. 15, 2011

Ono Pharmaceutical set to launch Corebeta in Japan

Sep. 14, 2011

Novartis gains E.U. approval for Votubia

Sep. 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...